SCHEMBL21765808

SCHEMBL21765808

COC(=O)C(C(=O)OC)C(=O)C1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
TSHR P16473 1/20 0.40
PADI1 Q9ULC6 1/20 0.39
PADI4 Q9UM07 1/20 0.39
TP53 P04637 1/20 0.39
ALDH1A1 P00352 3/20 0.37
NPSR1 Q6W5P4 2/20 0.37
SLC6A3 Q01959 1/20 0.36
THRB P10828 1/20 0.36
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
ADRB3 P13945 1/20 0.36
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3091676 0.80 SMN1; SMN2 (0.39) CES2CES1SMN1; SMN2HDAC8HDAC6
SCHEMBL3826078 0.80 SMN1; SMN2 (0.39) CES2CES1SMN1; SMN2HDAC8HDAC6
SCHEMBL6710646 0.79 SMN1; SMN2 (0.33) SMN1; SMN2TSHRALDH1A1THRB
SCHEMBL1617657 0.78 SMN1; SMN2 (0.40) CES2CES1SMN1; SMN2HDAC8HDAC6
SCHEMBL942071 0.78 ALDH1A1 (0.46) SMN1; SMN2TSHRALDH1A1NPSR1SLC6A3
SCHEMBL17504886 0.75 TSHR (0.40) SMN1; SMN2TSHRPADI1PADI4TP53
SCHEMBL27395269 0.74 CES2 (0.44) CES2CES1SMN1; SMN2HDAC8HDAC6
SCHEMBL29102026 0.73 CES2 (0.39) CES2CES1SMN1; SMN2HDAC8HDAC6
SCHEMBL2001451 0.73 ALDH1A1 (0.46) SMN1; SMN2TSHRALDH1A1NPSR1SLC6A3
SCHEMBL10901570 0.73 SMN1; SMN2 (0.34) CES2CES1SMN1; SMN2HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3613742-A1 INDOLIZINE DERIVATIVES AND APPLICATION THEREOF IN MEDICINE Kind Pharmaceutical (CN) 2020-02-26 EP disclosed